JP2023552829A5 - - Google Patents

Info

Publication number
JP2023552829A5
JP2023552829A5 JP2023534951A JP2023534951A JP2023552829A5 JP 2023552829 A5 JP2023552829 A5 JP 2023552829A5 JP 2023534951 A JP2023534951 A JP 2023534951A JP 2023534951 A JP2023534951 A JP 2023534951A JP 2023552829 A5 JP2023552829 A5 JP 2023552829A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
cdr
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/062485 external-priority patent/WO2022125712A1/en
Publication of JP2023552829A publication Critical patent/JP2023552829A/ja
Publication of JP2023552829A5 publication Critical patent/JP2023552829A5/ja
Pending legal-status Critical Current

Links

JP2023534951A 2020-12-09 2021-12-08 免疫細胞機能を調節するための変異インターロイキン-10ポリペプチドの抗原結合分子との融合物 Pending JP2023552829A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063123387P 2020-12-09 2020-12-09
US63/123,387 2020-12-09
US202163169604P 2021-04-01 2021-04-01
US63/169,604 2021-04-01
PCT/US2021/062485 WO2022125712A1 (en) 2020-12-09 2021-12-08 Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function

Publications (2)

Publication Number Publication Date
JP2023552829A JP2023552829A (ja) 2023-12-19
JP2023552829A5 true JP2023552829A5 (cg-RX-API-DMAC7.html) 2024-12-17

Family

ID=81973973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534951A Pending JP2023552829A (ja) 2020-12-09 2021-12-08 免疫細胞機能を調節するための変異インターロイキン-10ポリペプチドの抗原結合分子との融合物

Country Status (8)

Country Link
US (1) US20240010695A1 (cg-RX-API-DMAC7.html)
EP (1) EP4259645A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023552829A (cg-RX-API-DMAC7.html)
KR (1) KR20230129423A (cg-RX-API-DMAC7.html)
AU (1) AU2021396247A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204723A1 (cg-RX-API-DMAC7.html)
TW (1) TW202237630A (cg-RX-API-DMAC7.html)
WO (1) WO2022125712A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230112632A (ko) * 2020-10-23 2023-07-27 애셔 바이오테라퓨틱스, 인크. 면역 세포 기능을 조절하기 위한 cd8 항원 결합 분자와의 융합
WO2022245500A1 (en) 2021-05-19 2022-11-24 Asher Biotherapeutics, Inc. Il-21 polypeptides and targeted constructs
CN118206629B (zh) * 2022-12-16 2025-12-02 深圳莱芒生物科技有限公司 一种细胞因子白细胞介素10的突变体及其制备方法和应用
WO2024131600A1 (zh) * 2022-12-24 2024-06-27 广东菲鹏制药股份有限公司 Il10突变体、融合蛋白和药物
WO2026112381A1 (en) * 2024-11-22 2026-05-28 The Regents Of The University Of California Vaccines using macrophage suppression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001231532A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Improved interleukin 10
WO2004044006A1 (en) * 2002-11-14 2004-05-27 Maxygen, Inc. Conjugates of interleukin-10 and polymers
BR112016016658A2 (pt) * 2014-02-06 2018-01-23 F. Hoffmann-La Roche Ag proteína de fusão de um anticorpo, polinucleotídeo, vetor, célula hospedeira, composição farmacêutica, métodos para produzir uma proteína de fusão e de tratamento de uma doença em um indivíduo e uso da proteína de fusão
CN111655717A (zh) * 2018-01-26 2020-09-11 豪夫迈·罗氏有限公司 IL-22 Fc融合蛋白及使用方法
JP2022512746A (ja) * 2018-10-19 2022-02-07 アンブルックス,インコーポレイテッド インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
TW202031284A (zh) * 2018-11-08 2020-09-01 美商新索思股份有限公司 介白素10結合物及其用途
CN113811549A (zh) * 2019-02-21 2021-12-17 Xencor股份有限公司 非靶向和靶向性il-10 fc融合蛋白

Similar Documents

Publication Publication Date Title
JP2023548045A5 (cg-RX-API-DMAC7.html)
JP2023085476A5 (cg-RX-API-DMAC7.html)
JP2018537966A5 (cg-RX-API-DMAC7.html)
JP2022535130A5 (cg-RX-API-DMAC7.html)
WO2022087458A1 (en) Fusions with cd8 antigen binding molecules for modulating immune cell function
JP2021522162A5 (cg-RX-API-DMAC7.html)
CN111936514A (zh) 多价抗体
JP2021533779A5 (cg-RX-API-DMAC7.html)
IL292780A (en) A new 4-1bbl trimer containing antigen-binding molecules
US20240010695A1 (en) Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function
JP2024522069A5 (cg-RX-API-DMAC7.html)
CA3184746A1 (en) Anti-pd-1 antibodies and fusion proteins
JP2023524132A5 (cg-RX-API-DMAC7.html)
JP2024534783A5 (cg-RX-API-DMAC7.html)
JP2024532426A5 (cg-RX-API-DMAC7.html)
US20250339519A1 (en) Combination of cytokine fusion proteins with cd8 antigen binding molecules
JP2022513321A5 (cg-RX-API-DMAC7.html)
CN120112558A (zh) 治疗慢性病毒感染的含cd8抗原结合分子的融合物
CN116829577A (zh) 用于调节免疫细胞功能的突变型白介素-10多肽与抗原结合分子的融合物
WO2026037338A1 (zh) 一种阻断baff、april作用其受体的融合蛋白
JP2022537736A5 (cg-RX-API-DMAC7.html)
RU2021102799A (ru) Антитела, содержащие полипептид, встроенный в участок каркасной области 3
NZ807450A (en) Antibodies binding to gprc5d
RU2022104485A (ru) Антитела, связывающиеся с gprc5d
TH2101006347A (th) โปรตีนการจับชนิดไตรสเปซิฟิกและ/หรือไตรวาเลนต์ที่ใช้รูปแบบโดเมนแปรผันได้คู่ แบบไขว้ (codv) สำหรับการบำบัดการติดเชื้อ hiv